{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:33:47Z","timestamp":1791293627131,"version":"4.1.0"},"reference-count":39,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100012167","name":"National Science and Technology Infrastructure Program","doi-asserted-by":"publisher","award":["2013BAI09B12"],"award-info":[{"award-number":["2013BAI09B12"]}],"id":[{"id":"10.13039\/501100012167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012167","name":"National Science and Technology Infrastructure Program","doi-asserted-by":"publisher","award":["2015BAI12B13"],"award-info":[{"award-number":["2015BAI12B13"]}],"id":[{"id":"10.13039\/501100012167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1305000"],"award-info":[{"award-number":["2016YFC1305000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1309604"],"award-info":[{"award-number":["2017YFC1309604"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>This study applied the Swedish novel data-driven classification in Chinese newly diagnosed diabetic patients and validated its adoptability.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study aimed to validate the practicality of the Swedish diabetes regrouping scheme in Chinese adults with newly diagnosed diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Patients were classified into 5 subgroups by K-means and Two-Step methods according to 6 clinical parameters.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Ambulatory care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>A cross-sectional survey of 15 772 patients with adult-onset newly diagnosed diabetes was conducted in China from April 2015 to October 2017.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Intervention<\/jats:title>\n                  <jats:p>None.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Six parameters including glutamate decarboxylase antibodies (GADA), age of onset, body mass index (BMI), glycated hemoglobin A1c (HbA1c), homoeostatic model assessment 2 estimates of \u03b2-cell function (HOMA2-B) and insulin resistance (HOMA2-IR) were measured to calculate the patient subgroups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Our patients clustered into 5 subgroups: 6.2% were in the severe autoimmune diabetes (SAID) subgroup, 24.8% were in the severe insulin-deficient diabetes (SIDD) subgroup, 16.6% were in the severe insulin-resistance diabetes (SIRD) subgroup, 21.6% were in the mild obesity-related diabetes (MOD) subgroup and 30.9% were in the mild age-related diabetes (MARD) subgroup. When compared with the Swedish population, the proportion of SIDD subgroup was higher. In general, Chinese patients had younger age, lower BMI, higher HbA1c, lower HOMA2-B and HOMA2-IR, and higher insulin use but lower metformin usage than the Swedish patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The Swedish diabetes regrouping scheme is applicable to adult-onset diabetes in China, with a high proportion of patients with the severe insulin deficient diabetes. Further validations of long-term diabetes complications remain warranted in future studies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa524","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T01:36:58Z","timestamp":1597714618000},"page":"e3519-e3528","source":"Crossref","is-referenced-by-count":45,"title":["Validation of the Swedish Diabetes Re-Grouping Scheme in Adult-Onset Diabetes in China"],"prefix":"10.1210","volume":"105","author":[{"given":"Xia","family":"Li","sequence":"first","affiliation":[{"name":"Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China"},{"name":"Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, Changsha, China"},{"name":"National Clinical Research Center for Metabolic Diseases, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China"},{"name":"Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, Changsha, China"},{"name":"National Clinical Research Center for Metabolic Diseases, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqing","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China"},{"name":"Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, Changsha, China"},{"name":"National Clinical Research Center for Metabolic Diseases, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China"},{"name":"Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, Changsha, China"},{"name":"National Clinical Research Center for Metabolic Diseases, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zheng","sequence":"additional","affiliation":[{"name":"Changsha Fulcrum Information Technology Co. Ltd., Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanbo","family":"Zheng","sequence":"additional","affiliation":[{"name":"Changsha Fulcrum Information Technology Co. Ltd., Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Da","sequence":"additional","affiliation":[{"name":"Changsha Fulcrum Information Technology Co. Ltd., Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China"},{"name":"Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, Changsha, China"},{"name":"National Clinical Research Center for Metabolic Diseases, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Metabolism & Endocrinology, Peking University People\u2019s Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0374-1838","authenticated-orcid":false,"given":"Zhiguang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China"},{"name":"Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, Changsha, China"},{"name":"National Clinical Research Center for Metabolic Diseases, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"issue":"10027","key":"2021122106040204700_CIT0001","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants","volume":"387","author":"Collaboration NCDRF","year":"2016","journal-title":"Lancet."},{"issue":"3","key":"2021122106040204700_CIT0002","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00125-014-3462-y","article-title":"Epigenetic mechanisms in diabetic complications and metabolic memory","volume":"58","author":"Reddy","year":"2015","journal-title":"Diabetologia."},{"key":"2021122106040204700_CIT0003","first-page":"S124","article-title":"Microvascular complications and foot care","volume":"42","author":"Standards of Medical Care in Diabetes-201911","year":"2019","journal-title":"Diabetes Care."},{"key":"2021122106040204700_CIT0004","first-page":"S103","article-title":"Cardiovascular disease and risk management","volume":"42","author":"Standards of Medical Care in Diabetes-201910","year":"2019","journal-title":"Diabetes Care."},{"issue":"1","key":"2021122106040204700_CIT0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2337\/dc14-1770","article-title":"Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3)","volume":"38","author":"Liu","year":"2015","journal-title":"Diabetes Care."},{"issue":"8","key":"2021122106040204700_CIT0006","article-title":"Effect of multifactorial treatment targets and relative importance of hemoglobin A1c, blood pressure, and low-density lipoprotein-cholesterol on cardiovascular diseases in Chinese primary care patients with type 2 diabetes mellitus: a population-based retrospective cohort study","volume":"6","author":"Eyf","year":"2017","journal-title":"J Am Heart Assoc."},{"issue":"3","key":"2021122106040204700_CIT0007","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s00125-014-3448-9","article-title":"Age trajectories of glycaemic traits in non-diabetic South Asian and white individuals: the Whitehall II cohort study","volume":"58","author":"Ikehara","year":"2015","journal-title":"Diabetologia."},{"issue":"7","key":"2021122106040204700_CIT0008","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41574-018-0025-1","article-title":"Accurate diagnosis of diabetes mellitus and new paradigms of classification","volume":"14","author":"Chatterjee","year":"2018","journal-title":"Nat Rev Endocrinol."},{"issue":"5","key":"2021122106040204700_CIT0009","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"2021122106040204700_CIT0010","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S2213-8587(19)30087-7","article-title":"Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data","volume":"7","author":"Dennis","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9","key":"2021122106040204700_CIT0011","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","article-title":"Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study","volume":"7","author":"Zaharia","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2021122106040204700_CIT0012","doi-asserted-by":"crossref","DOI":"10.1111\/dom.14063","article-title":"Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER and SUSTAIN-6 cardiovascular outcomes trials","author":"Kahkoska","year":"2020","journal-title":"Diabetes Obes Metab."},{"issue":"1","key":"2021122106040204700_CIT0013","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S2213-8587(18)30316-4","article-title":"Novel subgroups of patients with adult-onset diabetes in Chinese and US populations","volume":"7","author":"Zou","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"2021122106040204700_CIT0014","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2337\/dc12-1235","article-title":"Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis","volume":"36","author":"Kodama","year":"2013","journal-title":"Diabetes Care."},{"issue":"11","key":"2021122106040204700_CIT0015","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1210\/jc.2014-1724","article-title":"Ethnic differences in insulin sensitivity, \u03b2-cell function, and hepatic extraction between Japanese and Caucasians: a minimal model analysis","volume":"99","author":"M\u00f8ller","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2021122106040204700_CIT0016","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med."},{"issue":"6","key":"2021122106040204700_CIT0017","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/dmrr.2779","article-title":"Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up","volume":"32","author":"Huang","year":"2016","journal-title":"Diabetes Metab Res Rev."},{"issue":"21","key":"2021122106040204700_CIT0018","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1001\/jama.291.21.2591","article-title":"Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study","volume":"291","author":"Liu","year":"2004","journal-title":"JAMA."},{"issue":"6","key":"2021122106040204700_CIT0019","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019agostino","year":"2008","journal-title":"Circulation."},{"key":"2021122106040204700_CIT0020","first-page":"2579","article-title":"Visualizing data using t-SNE","volume":"9","author":"Hinton","year":"2008","journal-title":"J Mach Learn Res."},{"key":"2021122106040204700_CIT0021","article-title":"Data from: validation of the Swedish diabetes regrouping scheme in adult-onset diabetes in China","author":"Li","year":"2020","journal-title":"Figshare."},{"key":"2021122106040204700_CIT0022","doi-asserted-by":"crossref","first-page":"l4894","DOI":"10.1136\/bmj.l4894","article-title":"HbA(1c) level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study","volume":"366","author":"Lind","year":"2019","journal-title":"BMJ."},{"issue":"20","key":"2021122106040204700_CIT0023","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1001\/jama.2009.726","article-title":"Diabetes in Asia: epidemiology, risk factors, and pathophysiology","volume":"301","author":"Chan","year":"2009","journal-title":"JAMA."},{"issue":"2","key":"2021122106040204700_CIT0024","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1463-1326.2011.01504.x","article-title":"Association of \u03b2-cell function and insulin sensitivity with fasting and 2-h plasma glucose in a large Chinese population","volume":"14","author":"Bi","year":"2012","journal-title":"Diabetes Obes Metab."},{"issue":"1","key":"2021122106040204700_CIT0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S2213-8587(15)00336-8","article-title":"10-year trajectory of \u03b2-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study","volume":"4","author":"Ohn","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"2021122106040204700_CIT0026","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00125-018-4557-7","article-title":"Epidemiology of diabetes and diabetic complications in China","volume":"61","author":"Ma","year":"2018","journal-title":"Diabetologia."},{"issue":"7","key":"2021122106040204700_CIT0027","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1007\/s00125-017-4275-6","article-title":"Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study","volume":"60","author":"Hulman","year":"2017","journal-title":"Diabetologia."},{"issue":"3","key":"2021122106040204700_CIT0028","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.diabres.2013.03.022","article-title":"Beta-cell function and insulin sensitivity at various degrees of glucose tolerance in Chinese subjects","volume":"100","author":"Lin","year":"2013","journal-title":"Diabetes Res Clin Pract."},{"issue":"3","key":"2021122106040204700_CIT0029","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1467-789X.2002.00065.x","article-title":"Asians are different from Caucasians and from each other in their body mass index\/body fat per cent relationship","volume":"3","author":"Deurenberg","year":"2002","journal-title":"Obes Rev."},{"issue":"2","key":"2021122106040204700_CIT0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcn\/86.2.353","article-title":"Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT)","volume":"86","author":"Lear","year":"2007","journal-title":"Am J Clin Nutr."},{"key":"2021122106040204700_CIT0031","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1467-789X.2007.00439.x","article-title":"Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension","volume":"9","author":"Huxley","year":"2008","journal-title":"Obes Rev."},{"issue":"2","key":"2021122106040204700_CIT0032","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00125-014-3414-6","article-title":"Comparison of HOMA-IR, HOMA-beta% and disposition index between US white men and Japanese men in Japan: the ERA JUMP study","volume":"58","author":"Ahuja","year":"2015","journal-title":"Diabetologia."},{"issue":"2","key":"2021122106040204700_CIT0033","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2337\/diacare.27.2.354","article-title":"Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women\u2019s Health Across the Nation (SWAN)","volume":"27","author":"Torr\u00e9ns","year":"2004","journal-title":"Diabetes Care."},{"issue":"12","key":"2021122106040204700_CIT0034","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S2213-8587(14)70136-6","article-title":"Early therapy for type 2 diabetes in China","volume":"2","author":"Yang","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"11","key":"2021122106040204700_CIT0035","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.2337\/diacare.27.11.2597","article-title":"Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function","volume":"27","author":"Li","year":"2004","journal-title":"Diabetes Care."},{"issue":"6","key":"2021122106040204700_CIT0036","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00044011-200727060-00003","article-title":"Post-marketing surveillance of acarbose treatment in patients with type 2 diabetes mellitus and subjects with impaired glucose tolerance in China","volume":"27","author":"Pan","year":"2007","journal-title":"Clin Drug Investig."},{"key":"2021122106040204700_CIT0037","volume-title":"IDF Diabetes Atlas.","author":"International Diabetes Federation","year":"2019","edition":"9"},{"issue":"10204","key":"2021122106040204700_CIT0038","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet."},{"issue":"9","key":"2021122106040204700_CIT0039","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2018-00422","article-title":"Regional differences in the prevalence of coronary heart disease and stroke in patients with type 2 diabetes in China","volume":"103","author":"Lyu","year":"2018","journal-title":"J Clin Endocrinol Metab."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa524\/33659139\/dgaa524.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/10\/e3519\/41827982\/dgaa524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/10\/e3519\/41827982\/dgaa524.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T06:04:55Z","timestamp":1640066695000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/10\/e3519\/5893635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,8,18]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa524","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,8,18]]}}}